X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
index medicus (129) 129
male (126) 126
middle aged (117) 117
female (116) 116
hepatocellular carcinoma (99) 99
gastroenterology & hepatology (94) 94
adult (81) 81
aged (70) 70
retrospective studies (60) 60
risk factors (57) 57
liver (36) 36
hepatitis b (35) 35
treatment outcome (34) 34
management (33) 33
liver cancer (32) 32
liver diseases (30) 30
survival (30) 30
carcinoma, hepatocellular - pathology (29) 29
liver neoplasms - pathology (28) 28
hepatoma (27) 27
original (27) 27
original article (27) 27
prognosis (27) 27
diagnosis (25) 25
hepatitis b virus (25) 25
surgery (25) 25
내과학 (25) 25
abridged index medicus (24) 24
antiviral agents - therapeutic use (24) 24
follow-up studies (24) 24
time factors (24) 24
cancer (23) 23
cirrhosis (23) 23
digestive system diseases (23) 23
hepatitis c (23) 23
risk (23) 23
carcinoma (22) 22
aged, 80 and over (21) 21
fibrosis (21) 21
transarterial chemoembolization (21) 21
ultrasonography (21) 21
analysis (20) 20
carcinoma, hepatocellular - therapy (20) 20
liver neoplasms - therapy (20) 20
oncology (20) 20
carcinoma, hepatocellular - mortality (19) 19
care and treatment (19) 19
hepatitis b, chronic - drug therapy (19) 19
liver neoplasms - mortality (19) 19
recurrence (19) 19
hepatocellular (18) 18
lamivudine (18) 18
liver cirrhosis (18) 18
liver neoplasms - surgery (18) 18
multivariate analysis (18) 18
predictive value of tests (18) 18
carcinoma, hepatocellular - surgery (17) 17
gastroenterology and hepatology (17) 17
hepatitis (17) 17
kaplan-meier estimate (17) 17
ribavirin (17) 17
viral load (17) 17
carcinoma, hepatocellular - virology (16) 16
chronic (16) 16
chronic hepatitis b (16) 16
proportional hazards models (16) 16
republic of korea - epidemiology (16) 16
therapy (16) 16
animals (15) 15
hepatitis b, chronic - complications (15) 15
infection (15) 15
liver neoplasms - virology (15) 15
prevalence (15) 15
research article (15) 15
resection (15) 15
disease progression (14) 14
hepatitis c virus (14) 14
hepatocellular-carcinoma (14) 14
medicine, general & internal (14) 14
neoplasm staging (14) 14
severity of illness index (14) 14
apoptosis (13) 13
efficacy (13) 13
fatty liver (13) 13
hepatology (13) 13
incidence (13) 13
liver transplantation (13) 13
mortality (13) 13
patients (13) 13
republic of korea (13) 13
risk-factors (13) 13
steatosis (13) 13
tomography, x-ray computed (13) 13
epidemiology (12) 12
expression (12) 12
gastroenterology (12) 12
korea (12) 12
liver - pathology (12) 12
medicine (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 02/2015, Volume 125, Issue 2, pp. 539 - 550
In contrast to microbially triggered inflammation, mechanisms promoting sterile inflammation remain poorly understood. Damage-associated molecular patterns... 
MEDICINE, RESEARCH & EXPERIMENTAL | DANGER SIGNALS | STERILE INFLAMMATION | CHROMATIN PROTEIN HMGB1 | IN-VIVO | SEPTIC SHOCK | MOBILITY GROUP BOX-1 | RECEPTOR | DEFICIENT MICE | CELL-DEATH | TRANSGENIC MICE | Acetaminophen - adverse effects | Inflammation - chemically induced | Leukocyte Elastase - metabolism | Tumor Necrosis Factor-alpha - metabolism | Inflammation - pathology | Tumor Necrosis Factor-alpha - genetics | Analgesics, Non-Narcotic - pharmacology | Hepatocytes - pathology | Hepatocytes - metabolism | Neutrophil Infiltration | fas Receptor - metabolism | Necrosis - pathology | HMGB1 Protein - genetics | Shock, Septic - metabolism | Inflammation - metabolism | Acetaminophen - pharmacology | Analgesics, Non-Narcotic - adverse effects | HMGB1 Protein - metabolism | fas Receptor - genetics | Chemical and Drug Induced Liver Injury - pathology | Neutrophils - metabolism | Receptor for Advanced Glycation End Products | Neutrophils - pathology | Shock, Septic - genetics | Shock, Septic - pathology | Lipopolysaccharides - toxicity | Macrophages - pathology | Shock, Septic - chemically induced | Leukocyte Elastase - genetics | Necrosis - metabolism | Chemical and Drug Induced Liver Injury - genetics | Mice, Knockout | Necrosis - chemically induced | Macrophages - metabolism | Animals | Chemical and Drug Induced Liver Injury - metabolism | Inflammation - genetics | Mice | Necrosis - genetics | Receptors, Immunologic - genetics | Receptors, Immunologic - metabolism | Physiological aspects | Causes of | Inflammation | Genetic aspects | Cell death | Necrosis | Chromosomal proteins | Mass spectrometry | Analysis | Proteins | Studies | Rodents | Mortality | Gangrene | Homeostasis | Mitochondrial DNA | Laboratory animals | Deoxyribonucleic acid--DNA | Apoptosis
Journal Article
대한소화기학회지, ISSN 1598-9992, 2016, Volume 67, Issue 3, p. 137
HCV-related decompensated liver cirrhosis is a life-threatening illness with an average 5-year survival rate of 50%. Because these patients have higher risk of... 
Direct-acting antiviral agents | Decompensated liver cirrhosis | Hepatitis C virus
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 143, Issue 4, pp. 1073 - 1083.e22
Journal Article
Korean Journal of Medicine, ISSN 1738-9364, 2015, Volume 88, Issue 6, p. 643
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 7, pp. 1383 - 1391.e6
Journal Article
Journal Article
Journal Article
Journal Article
The Journal of Korean Diabetes, ISSN 2233-7431, 06/2014, Volume 15, Issue 2, pp. 82 - 92
Journal Article
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, ISSN 1598-9992, 03/2016, Volume 67, Issue 3, pp. 137 - 141
HCV-related decompensated liver cirrhosis is a life-threatening illness with an average 5-year survival rate of 50%. Because these patients have higher risk of... 
Hepatitis C virus | Direct-acting antiviral agents | Decompensated liver cirrhosis
Journal Article
Gut, ISSN 0017-5749, 12/2014, Volume 63, Issue 12, pp. 1943 - 1950
Background It is generally stated that oral antiviral therapy in patients with chronic hepatitis B (CHB) decreases the risk of developing hepatocellular... 
TERM LAMIVUDINE THERAPY | HBSAG SEROCLEARANCE | HEPATOCELLULAR-CARCINOMA | VIRUS-DNA | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | Carcinoma, Hepatocellular - epidemiology | Liver - pathology | Hepatitis B, Chronic - immunology | Outcome Assessment (Health Care) | Guanine - analogs & derivatives | Carcinoma, Hepatocellular - prevention & control | Humans | Middle Aged | Arabinofuranosyluracil - therapeutic use | Male | Time | Arabinofuranosyluracil - analogs & derivatives | Incidence | Liver Neoplasms - etiology | Liver Neoplasms - epidemiology | Hepatitis B, Chronic - physiopathology | Lamivudine - therapeutic use | Adult | Female | Carcinoma, Hepatocellular - etiology | Retrospective Studies | Republic of Korea - epidemiology | Hepatitis B virus - immunology | Guanine - therapeutic use | Liver Neoplasms - prevention & control | Risk Assessment | Antiviral Agents - therapeutic use | Hepatitis B, Chronic - epidemiology | Liver Cirrhosis - complications | Risk Factors | Kaplan-Meier Estimate | Patient Acuity | Hepatitis B, Chronic - complications | Hepatitis B, Chronic - drug therapy | Hepatitis B e Antigens - blood | Antiviral agents | Care and treatment | Control | Dosage and administration | Hepatoma | Hepatitis B | Studies | Liver cancer | Hepatitis | Surveillance | Biopsy | Biomarkers | Interferon | Infections | Liver cirrhosis | Deoxyribonucleic acid--DNA
Journal Article
Journal of Hepatology, ISSN 0168-8278, 12/2017, Volume 67, Issue 6, pp. 1274 - 1280
Journal Article